FilingSEC EDGAR6-K
Addex Therapeutics Issues 93 Million New Shares for Future Financing Flexibility
· SEC accepted
StageCapital structure adjustment
Filing content
The company announced the issuance of 93 million new shares, fully subscribed by its 100% wholly-owned subsidiary Addex Pharma S.A., to provide future financing flexibility.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…